tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics, Inc. (FDMT)
:FDMT
US Market
Advertisement

4D Molecular Therapeutics (FDMT) Stock News & Sentiment

Compare
438 Followers
Buy Rating Affirmed for 4D-150: Promising Phase 2a SPECTRA Trial Results and Market Potential
Premium
Ratings
Buy Rating Affirmed for 4D-150: Promising Phase 2a SPECTRA Trial Results and Market Potential
2M ago
4D Molecular Therapeutics Faces Revenue Challenges Amid Complex Reimbursement Landscape
Premium
Company Announcements
4D Molecular Therapeutics Faces Revenue Challenges Amid Complex Reimbursement Landscape
2M ago
4D Molecular Therapeutics Advances Clinical Programs in Q2 2025
Premium
Company Announcements
4D Molecular Therapeutics Advances Clinical Programs in Q2 2025
2M ago
Promising Phase 2 Trial Results and Strategic Developments Support Buy Rating for 4D Molecular Therapeutics
Premium
Ratings
Promising Phase 2 Trial Results and Strategic Developments Support Buy Rating for 4D Molecular Therapeutics
2M ago
Promising Potential of 4D-150 in DME and wAMD: Buy Rating Affirmed by Analyst
Premium
Ratings
Promising Potential of 4D-150 in DME and wAMD: Buy Rating Affirmed by Analyst
2M ago
Promising Phase 2a SPECTRA Trial Results and Strategic Focus Drive Buy Rating for 4D-150 in Diabetic Macular Edema
Premium
Ratings
Promising Phase 2a SPECTRA Trial Results and Strategic Focus Drive Buy Rating for 4D-150 in Diabetic Macular Edema
2M ago
Bullish Outlook on 4D Molecular Therapeutics’ 4D-150: Promising Clinical Data and Market Potential in Diabetic Macular Edema Treatment
Premium
Ratings
Bullish Outlook on 4D Molecular Therapeutics’ 4D-150: Promising Clinical Data and Market Potential in Diabetic Macular Edema Treatment
2M ago
More FDMT News >

News Score - Last 7 Days

Neutral
FDMT
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FDMT’s Media Buzz Sentiment?
Currently, no data Available
What is FDMT’s weekly average amount of articles?
Currently, no data Available
What is FDMT’s News Sentiment?
59% of articles about FDMT were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    ARQTArcutis Biotherapeutics
    COLLCollegium Pharmaceutical
    PXSProvexis
    PRMProteome Sciences
    0EFOFidia Spa
    Showing the stocks with the most bullish news sentiment over the past week
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis